Amoeba SA (ALMIB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.644x

Based on the latest financial reports, Amoeba SA (ALMIB) has a cash flow conversion efficiency ratio of 0.644x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.45 Million ≈ $-4.04 Million USD) by net assets (€-5.36 Million ≈ $-6.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Amoeba SA (ALMIB) net asset quality to measure how much of total assets are equity-financed.

Amoeba SA - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Amoeba SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of Amoeba SA to assess the company's total reinvestment commitment from operating cash flow.

Amoeba SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amoeba SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Oceanic Iron Ore Corp
V:FEO
0.004x
YTN Co.Ltd
KQ:040300
-0.005x
Principal Real Estate Income Closed Fund
NYSE:PGZ
0.029x
Osmond Resources Ltd
AU:OSM
-0.021x
Territorial Bancorp Inc
NASDAQ:TBNK
-0.003x
NSTS Bancorp Inc
NASDAQ:NSTS
0.069x
Clene Inc.
NASDAQ:CLNN
0.241x
Tex Cycle Technology M Bhd
KLSE:0089
0.002x

Annual Cash Flow Conversion Efficiency for Amoeba SA (2012–2025)

The table below shows the annual cash flow conversion efficiency of Amoeba SA from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see ALMIB stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-5.36 Million
≈ $-6.27 Million
€-6.13 Million
≈ $-7.16 Million
1.143x +182.19%
2024-12-31 €-10.41 Million
≈ $-12.17 Million
€-4.22 Million
≈ $-4.93 Million
0.405x -75.44%
2023-12-31 €-3.94 Million
≈ $-4.61 Million
€-6.50 Million
≈ $-7.60 Million
1.649x +349.19%
2022-12-31 €8.16 Million
≈ $9.54 Million
€-5.40 Million
≈ $-6.32 Million
-0.662x +97.77%
2021-12-31 €198.68K
≈ $232.28K
€-5.90 Million
≈ $-6.90 Million
-29.704x -1727.93%
2020-12-31 €2.00 Million
≈ $2.34 Million
€-3.25 Million
≈ $-3.80 Million
-1.625x -89.00%
2019-12-31 €4.23 Million
≈ $4.94 Million
€-3.64 Million
≈ $-4.25 Million
-0.860x +12.73%
2018-12-31 €5.41K
≈ $6.33K
€-5.33K
≈ $-6.23K
-0.985x -142.87%
2017-12-31 €12.52K
≈ $14.64K
€-5.08K
≈ $-5.94K
-0.406x -32.43%
2016-12-31 €18.63K
≈ $21.78K
€-5.71K
≈ $-6.67K
-0.306x +22.04%
2015-12-31 €10.60K
≈ $12.39K
€-4.16K
≈ $-4.87K
-0.393x +7.81%
2014-12-31 €2.80 Million
≈ $3.27 Million
€-1.19 Million
≈ $-1.39 Million
-0.426x -136.98%
2013-12-31 €433.99K
≈ $507.38K
€500.21K
≈ $584.79K
1.153x +771.59%
2012-12-31 €947.20K
≈ $1.11 Million
€-162.56K
≈ $-190.04K
-0.172x --

About Amoeba SA

PA:ALMIB France Agricultural Inputs
Market Cap
$66.38 Million
€56.78 Million EUR
Market Cap Rank
#20761 Global
#326 in France
Share Price
€0.73
Change (1 day)
+1.96%
52-Week Range
€0.66 - €1.16
All Time High
€38.22
About

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more